REGENXBIO Stock Price - RGNX

33.88
0.00 (0.0%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
Company Name Stock Ticker Symbol Market Type
REGENXBIO Inc RGNX NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
1.34 4.12% 33.88 30.23 34.56 30.97 32.54 20:00:00
Bid Price Ask Price Spread Spread % News
26.00 34.80 8.80 25.29% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
5,709 567,945 $ 32.36 $ 18,380,814 639,551 20.03 - 59.98
Last Trade Time Type Quantity Stock Price Currency
16:56:07 average 20,530 $ 33.88 USD

REGENXBIO Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 1.26B 37.14M $ 99.94M -2.59 - 36.68M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

REGENXBIO News

Loading Messages....

Latest RGNX Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical RGNX Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week26.3034.9425.6030.51589,4747.5828.82%
1 Month39.6743.3320.0331.31679,474-5.79-14.6%
3 Months38.5554.9720.0339.52524,326-4.67-12.11%
6 Months33.4554.9720.0339.35514,2180.431.29%
1 Year57.7559.9820.0342.34528,459-23.87-41.33%
3 Years19.8585.1016.3044.59467,17114.0370.68%
5 Years30.2685.107.070140.38368,9763.6211.96%

REGENXBIO Description

Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno-associated virus gene therapy to correct an underlying genetic defect. The diseases that Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa).


Your Recent History
NASDAQ
RGNX
REGENXBIO
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.